A. Duca

930 total citations
4 papers, 95 citations indexed

About

A. Duca is a scholar working on Psychiatry and Mental health, Clinical Psychology and Neurology. According to data from OpenAlex, A. Duca has authored 4 papers receiving a total of 95 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Clinical Psychology and 1 paper in Neurology. Recurrent topics in A. Duca's work include Schizophrenia research and treatment (4 papers), Healthcare Decision-Making and Restraints (2 papers) and Parkinson's Disease Mechanisms and Treatments (1 paper). A. Duca is often cited by papers focused on Schizophrenia research and treatment (4 papers), Healthcare Decision-Making and Restraints (2 papers) and Parkinson's Disease Mechanisms and Treatments (1 paper). A. Duca collaborates with scholars based in United States, Spain and Denmark. A. Duca's co-authors include Robert D. McQuade, Timothy Peters-Strickland, Anna Eramo, B. Johnson, Ross A. Baker, Raymond Sanchez, John M. Kane, Cathy Zhao, Joan Zhao and Pamela Perry and has published in prestigious journals such as European Neuropsychopharmacology, Journal of Medical Economics and Schizophrenia.

In The Last Decade

A. Duca

4 papers receiving 90 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Duca United States 3 93 35 24 17 15 4 95
Rajinder Shiwach United States 3 68 0.7× 16 0.5× 19 0.8× 13 0.8× 7 0.5× 4 101
Jeffrey D. Simmons United States 5 128 1.4× 21 0.6× 24 1.0× 10 0.6× 13 0.9× 13 181
N. Maruta Ukraine 4 151 1.6× 40 1.1× 43 1.8× 44 2.6× 28 1.9× 33 186
Vishal Sinha India 6 104 1.1× 15 0.4× 54 2.3× 8 0.5× 4 0.3× 17 160
Abraham Myerson United States 4 47 0.5× 17 0.5× 14 0.6× 5 0.3× 10 0.7× 5 98
Aseel Al‐Jadiri United States 5 78 0.8× 12 0.3× 48 2.0× 14 0.8× 2 0.1× 10 109
S. Lynch United Kingdom 5 100 1.1× 16 0.5× 91 3.8× 13 0.8× 3 0.2× 6 187
Elaine Weatherley-Jones United Kingdom 5 33 0.4× 12 0.3× 3 0.1× 10 0.6× 19 1.3× 6 203
Diana Pham United States 3 23 0.2× 7 0.2× 23 1.0× 6 0.4× 4 0.3× 6 58
W.K. Tay Singapore 2 29 0.3× 11 0.3× 7 0.3× 6 0.4× 3 0.2× 2 29

Countries citing papers authored by A. Duca

Since Specialization
Citations

This map shows the geographic impact of A. Duca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Duca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Duca more than expected).

Fields of papers citing papers by A. Duca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Duca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Duca. The network helps show where A. Duca may publish in the future.

Co-authorship network of co-authors of A. Duca

This figure shows the co-authorship network connecting the top 25 collaborators of A. Duca. A scholar is included among the top collaborators of A. Duca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Duca. A. Duca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Peters-Strickland, Timothy, Ross A. Baker, Robert D. McQuade, et al.. (2015). Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study. Schizophrenia. 1(1). 15039–15039. 12 indexed citations
2.
Kane, John M., Cathy Zhao, B. Johnson, et al.. (2014). Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis. Journal of Medical Economics. 18(2). 145–154. 41 indexed citations
3.
Peters-Strickland, Timothy, Robert A. Baker, Robert D. McQuade, et al.. (2014). P.3.d.035 Aripiprazole once-monthly for long-term maintenance treatment of schizophrenia: a 52-week open-label study. European Neuropsychopharmacology. 24. S542–S542. 1 indexed citations
4.
Kane, John M., Raymond Sanchez, Joan Zhao, et al.. (2013). Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia. Journal of Medical Economics. 16(7). 917–925. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026